CClinicalTrials.gg
Active, not recruitingNCT06892470Updated Mar 24, 2025

Visual Quality of Cataract Patients with High Myopia After Implantation of Different Intraocular Lenses

An observational study in Cataract, sponsored by Wenzhou Medical University. Active, not recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2025-03-24.

Sponsored by Wenzhou Medical University · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
62
Sex
All
01

Study summary

This prospective study aims to compare the visual outcomes following the implantation of two different types of multifocal intraocular lenses (IOLs) in highly myopic patients. The study will evaluate visual quality, refractive outcomes, and patient satisfaction using various visual assessment techniques and subjective satisfaction surveys.

02

Conditions studied

  • Cataract

Browse trials for

03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's planned enrollment of 62 is below the median of 81 across 484 observational studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Wenzhou Medical University is the lead sponsor of 93 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals who undergo micro-incision cataract surgery and implantation of targeted intraocular lenses at the Hangzhou Branch of Wenzhou Medical University Eye Hospital.

Inclusion criteria

  • 1: Patients are older than 18 years

    2: The axial length (AL) measured by IOLMaster 700 is ≥26 mm

    3: No anterior or posterior segment pathology that could potentially compromise visual potential (such as glaucoma, myopic traction maculopathy, corneal leukoma, etc.).

    4: Able to understand, cooperate, and complete all follow - ups

Exclusion criteria

Exclusion Criteria:

  • 1: History of amblyopia

    2: Retinal detachment in the same eye or the fellow eye

    3: Presence of multiple peripheral retinal degenerative changes

    4: History of previous ocular surgery

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
62 participants (estimated)
Patient registry
No

Groups and cohorts

  • TNF Group:

    Implantation of PanOptix trifocal IOL

    Other: No intervention

  • ZFR Group:

    Implantation of Tecnis Symfony ZFR00 extended depth of focus IOL (Johnson \& Johnson)

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Defocus Curve

    The defocus curve is a tool used to assess visual acuity, particularly widely applied in evaluating the performance of presbyopia-correcting intraocular lenses (IOLs). Its principle involves placing a series of positive and negative lenses of varying diopters in front of the patient's eyes to simulate different distances from near to far, thereby assessing the patient's visual acuity (VA) at each simulated distance.

    Time frame: Three months after operation

  2. Visual Questionnaire

    A visual questionnaire is a tool used to assess patients' visual function and quality of life. It typically includes a series of questions covering various aspects such as visual acuity at different distances (e.g., distance, intermediate, and near vision), dependency on glasses, and the impact of vision on the quality of life. By using a visual questionnaire, one can understand the actual visual experience and satisfaction of patients after the implantation of an intraocular lens.

    Time frame: Three months after operation

07

Study locations

1 site
  • Ophthalmology and Optometry Hos
    Hanzhou, zhejian, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06892470
Lead sponsor
Wenzhou Medical University
Responsible party
Yune Zhao (Vice president of Eye Hospital of Wenzhou Medical University, Wenzhou Medical University) — Principal investigator
First posted
Mar 24, 2025
Start date
Mar 1, 2025
Primary completion
May 30, 2026 (estimated)
Completion
May 30, 2026 (estimated)
Last update
Mar 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion